Fig. 1
From: SGLT2 inhibition mitigates intracerebral hemorrhage risk by modulating inflammation

Overview of the study design. GWAS, genome-wide association study; SNP, single nucleotide polymorphism; MR, Mendelian randomization.
From: SGLT2 inhibition mitigates intracerebral hemorrhage risk by modulating inflammation

Overview of the study design. GWAS, genome-wide association study; SNP, single nucleotide polymorphism; MR, Mendelian randomization.